Centrica


Disappointing H2 19, poor FY20 outlook

13/02/20 -"Disappointing full-year results after a 9m trading statement that had seemed encouraging. Adjusted operating profit came in short at £901m, however the adjusted EPS came in perfectly in line with the ..."

Pages
56
Language
English
Published on
13/02/20
You may also be interested by these reports :
29/07/26
Hera reported H1 26 in line with our estimates, with adjusted EBITDA up 7.5% to €715.5m, supported by contributions across all business areas. We ...

29/07/26
We have updated our model following Iberdrola’s H1’26 results and the announcement of its acquisition of an 80% stake in Finnish DSO Caruna for ...

29/07/26
Solid H1 26, broadly in line. EBITDA reached €1,572m, up €80m (+5.4%, or +9.2% ex one-off) YoY, driven mainly by higher regulated revenues in Gas ...

29/07/26
RWE posted solid H1 26 results, boosted by Offshore Wind and Flexible Generation, and c.€100m one-off on Supply & Trading. This lifts 2026E EPS ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO